Trial Profile
Clinical Trials Insight: 700030110
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 25 Jan 2008
Price :
$35
*
At a glance
- Drugs HSV thymidine kinase gene therapy (Primary)
- Indications Haematological malignancies
- Focus Therapeutic Use
- Sponsors MolMed
- 25 Jan 2008 New trial record.